Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis

One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading...

Full description

Saved in:
Bibliographic Details
Published inRNA biology Vol. 16; no. 11; pp. 1592 - 1603
Main Authors Ou, Zheng-Lin, Luo, Zhen, Wei, Wei, Liang, Shuai, Gao, Tai-Long, Lu, Ye-Bin
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 02.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Abbreviations: Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D);
AbstractList One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Abbreviations: Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D);
One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D).
One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Abbreviations: Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D).One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Abbreviations: Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D).
One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Abbreviations: Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D);
One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment plays a causal role in PC metastasis. According to previous studies, hypoxia could induce the upregulation of HIF1A, ADAM10 and sMICA, leading to decreased NKG2D in NK cells and tumour cells escape from immune surveillance and NK cell-mediated lysis. In the present study, in NK cells derived from high-HIF1A expression patients, the levels of internalization of MICA/B and NKG2D were obviously higher than those in low-HIF1A expression group; hypoxia dramatically upregulated the levels of sMICA culture supernatant of Panc-1 cells. Regarding the molecular mechanism, dysregulated circRNAs and miRNAs that might modulate HIF1A-mediated immune escape were selected and examined for detailed functions. The expression of circ_0000977 could be induced by hypoxia, and circ_0000977 knockdown enhanced the killing effect of NK cells on PC cells under hypoxia through HIF1A and ADAM10. HIF1 and ADAM10 were direct downstream targets of miR-153; circ_0000977 served as a sponge for miR-153 to counteract miR-153-mediated repression of HIF1 and ADAM10 mRNA through direct targeting in both 293T cells and Panc-1 cells. miR-153 inhibition exerted an opposing effect on HIF1A-mediated immune escape of PC cells to circ_0000977 knockdown; the effect of circ_0000977 knockdown were partially attenuated by miR-153 inhibition. In summary, circ_0000977/miR-153 axis modulates HIF1A-mediated immune escape of PC cells through miR-153 downstream targets HIF1A and ADAM10. We provided a novel mechanism of HIF1A-mediated immune escape of PC cells from the perspective of circRNAs-miRNA-mRNA axis. Abbreviations: Pancreatic cancer (PC); peripheral blood lymphocytes (PBLs); A Disintegrin and Metalloproteinase Domain 10 (ADAM10); MHC class I-related molecule A (MICA); soluble MICA (sMICA); membrane MICA (mMICA); Hypoxia-inducible factor 1-alpha (HI1FA); long non-coding RNAs (lncRNAs); non-coding RNAs (ncRNAs); natural killer (NK); Haematoxylin and eosin (H&E); Immunohistochemistry (IHC); natural killer group 2 member D (NKG2D);
Author Lu, Ye-Bin
Wei, Wei
Luo, Zhen
Gao, Tai-Long
Liang, Shuai
Ou, Zheng-Lin
Author_xml – sequence: 1
  givenname: Zheng-Lin
  surname: Ou
  fullname: Ou, Zheng-Lin
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 2
  givenname: Zhen
  orcidid: 0000-0003-2444-5138
  surname: Luo
  fullname: Luo, Zhen
  organization: Department of General Surgery, The Third Xiangya Hospital, Central South University
– sequence: 3
  givenname: Wei
  surname: Wei
  fullname: Wei, Wei
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 4
  givenname: Shuai
  surname: Liang
  fullname: Liang, Shuai
  organization: Department of General Surgery, Xiangya Hospital, Central South University
– sequence: 5
  givenname: Tai-Long
  surname: Gao
  fullname: Gao, Tai-Long
  organization: Department of Hepatobiliary Surgery, Hunan People's Hospital
– sequence: 6
  givenname: Ye-Bin
  surname: Lu
  fullname: Lu, Ye-Bin
  email: luyebin6@sina.com
  organization: Department of General Surgery, Xiangya Hospital, Central South University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31402756$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1vFCEUhompsR_6EzRcejNbGL4GTYxNY93GqonRa8Iw0GJmYAoz2v0R_mcZd9eoF5YbDuE5L-_hnGNwEGKwADzFaIVRg04xo4LXDV_VCMsV5lSyhj0AR5gxVjWsoQdLTEW1QIfgOOevCBHeSPYIHBJMUS0YPwI_1psx3nld-dDNxnYw39iu8-EaRgffX56fQR06uL68wGfVYDuvp8L4YZiDhTYbPdoFHHUwyerJG2hKaBM0tu8zdCkO8MO77ekFTLH_hRufjEJlSSFOB_-pwoxAfefzY_DQ6T7bJ7v9BHy5ePP5fF1dfXxbvFxVhnExVdYSYzDnXYM71xIriWs1FZZJiY0jglKLDKZtqxveSSO1LKQxUiDZttQ5cgJebXXHuS1VGRumpHs1Jj_otFFRe_X3TfA36jp-U1wISSQuAs93AinezjZPavB5qVIHG-esakoRl0Rgfj9ai7rGHNeioM_-tPXbz75dBXi5BUyKOSfrlPFT-fa4uPS9wkgtw6H2w6GW4VC74SjZ7J_s_QP35b3e5vngYhr095j6Tk1608fkUum3z8XifyV-Agbh0DE
CitedBy_id crossref_primary_10_1186_s12943_022_01615_8
crossref_primary_10_3390_cells12020273
crossref_primary_10_1016_j_envres_2023_116573
crossref_primary_10_3892_ijo_2020_5054
crossref_primary_10_3389_fcell_2022_829404
crossref_primary_10_1016_j_yexcr_2023_113764
crossref_primary_10_1007_s12032_022_01653_8
crossref_primary_10_1016_j_ncrna_2023_03_005
crossref_primary_10_3389_fphar_2022_949713
crossref_primary_10_1021_acsanm_3c03454
crossref_primary_10_1016_j_semcdb_2021_05_029
crossref_primary_10_3892_ijo_2022_5346
crossref_primary_10_1186_s12943_019_1125_9
crossref_primary_10_3389_fimmu_2022_929677
crossref_primary_10_3390_cancers15041155
crossref_primary_10_3389_fcell_2022_1023332
crossref_primary_10_1155_2023_6891636
crossref_primary_10_1053_j_gastro_2025_01_240
crossref_primary_10_3389_fimmu_2021_728062
crossref_primary_10_1016_j_coi_2020_10_010
crossref_primary_10_32604_biocell_2021_012519
crossref_primary_10_3389_fonc_2021_665246
crossref_primary_10_1007_s12032_022_01669_0
crossref_primary_10_1186_s40364_022_00380_6
crossref_primary_10_1186_s40364_023_00530_4
crossref_primary_10_3390_cancers12113250
crossref_primary_10_1038_s41392_023_01480_x
crossref_primary_10_3390_immuno5010008
crossref_primary_10_1186_s12935_020_01245_4
crossref_primary_10_1111_febs_16643
crossref_primary_10_1186_s13046_020_1535_y
crossref_primary_10_1016_j_canlet_2020_04_018
crossref_primary_10_3389_fimmu_2022_894707
crossref_primary_10_1186_s12943_021_01406_7
crossref_primary_10_1038_s12276_022_00877_y
crossref_primary_10_3390_cancers15061743
crossref_primary_10_1186_s12935_020_01301_z
crossref_primary_10_3389_fonc_2021_596798
crossref_primary_10_1007_s13402_020_00521_9
crossref_primary_10_1016_j_biopha_2022_113992
crossref_primary_10_1016_j_ejphar_2023_175535
crossref_primary_10_1016_j_ijbiomac_2023_124929
crossref_primary_10_3390_biomedicines12092072
crossref_primary_10_1089_ars_2022_0035
crossref_primary_10_1038_s41419_022_05114_y
crossref_primary_10_1016_j_semcancer_2022_03_002
crossref_primary_10_3892_ol_2022_13492
crossref_primary_10_1186_s12964_021_00806_y
crossref_primary_10_1007_s10863_023_09985_4
crossref_primary_10_1016_j_semcancer_2023_11_008
crossref_primary_10_1097_CM9_0000000000002619
crossref_primary_10_1155_2022_3522492
crossref_primary_10_1186_s12964_021_00742_x
crossref_primary_10_1038_s41420_022_00983_w
crossref_primary_10_3390_cancers13030405
crossref_primary_10_1186_s12943_022_01567_z
crossref_primary_10_3389_fgene_2022_823238
crossref_primary_10_1080_2162402X_2022_2138152
crossref_primary_10_1186_s13045_020_00848_8
crossref_primary_10_3748_wjg_v27_i24_3483
crossref_primary_10_1016_j_cca_2023_117633
crossref_primary_10_1615_CritRevImmunol_2024052389
crossref_primary_10_1080_10409238_2022_2088684
crossref_primary_10_1016_j_imlet_2024_106898
crossref_primary_10_1007_s11010_024_05186_8
crossref_primary_10_3389_fimmu_2020_00447
crossref_primary_10_3390_cancers14225475
crossref_primary_10_3389_fcell_2020_599494
crossref_primary_10_1158_1078_0432_CCR_22_3836
crossref_primary_10_1016_j_phrs_2020_104691
crossref_primary_10_1038_s41419_023_05647_w
crossref_primary_10_1038_s41420_024_02092_2
crossref_primary_10_2174_1389450123666220111114649
crossref_primary_10_3389_fimmu_2022_833058
crossref_primary_10_1136_jitc_2023_008040
crossref_primary_10_1111_jcmm_16089
crossref_primary_10_3892_or_2024_8796
crossref_primary_10_1016_j_biopha_2021_111351
crossref_primary_10_3390_cancers13133154
crossref_primary_10_3892_ol_2021_12908
crossref_primary_10_4014_jmb_2201_01010
crossref_primary_10_1038_s41420_024_01815_9
crossref_primary_10_3389_fimmu_2022_951561
crossref_primary_10_3390_cancers14092291
crossref_primary_10_2174_26669587_v2_e221026_2022_23
crossref_primary_10_1016_j_canlet_2022_215868
crossref_primary_10_3390_cells10123313
crossref_primary_10_3389_fimmu_2021_680435
crossref_primary_10_1186_s12885_024_12182_0
crossref_primary_10_1186_s13046_021_01894_x
crossref_primary_10_3389_fimmu_2024_1480572
crossref_primary_10_1016_j_gendis_2022_07_009
crossref_primary_10_1016_j_pan_2024_04_004
crossref_primary_10_12998_wjcc_v9_i34_10400
crossref_primary_10_1016_j_prp_2024_155259
crossref_primary_10_1002_med_21771
crossref_primary_10_3748_wjg_v27_i28_4582
crossref_primary_10_3389_fonc_2023_1153207
crossref_primary_10_1080_08916934_2020_1750011
crossref_primary_10_1186_s12935_020_01367_9
crossref_primary_10_1080_2162402X_2021_1974233
crossref_primary_10_1016_j_canlet_2023_216345
crossref_primary_10_20517_cdr_2024_66
crossref_primary_10_3389_fimmu_2021_641883
crossref_primary_10_1186_s13045_020_01030_w
crossref_primary_10_3389_fimmu_2022_1081546
crossref_primary_10_1016_j_pharmthera_2021_107869
crossref_primary_10_1186_s12935_020_01370_0
crossref_primary_10_1021_acsptsci_3c00394
crossref_primary_10_3389_fimmu_2022_1059376
crossref_primary_10_1186_s12935_021_02017_4
crossref_primary_10_3390_cancers12071872
crossref_primary_10_1016_j_semcancer_2020_12_026
crossref_primary_10_1186_s13073_020_00787_6
crossref_primary_10_3389_fcell_2021_718991
crossref_primary_10_1007_s00018_021_03929_0
crossref_primary_10_1016_j_ymthe_2022_12_005
crossref_primary_10_2147_CMAR_S308809
crossref_primary_10_1186_s13578_022_00833_3
crossref_primary_10_1186_s12943_019_1113_0
crossref_primary_10_3390_cells11091381
crossref_primary_10_1111_jgh_16536
crossref_primary_10_3390_genes16020140
Cites_doi 10.1158/0008-5472.CAN-11-2104
10.3389/fphar.2018.00415
10.3390/genes8120348
10.1186/s12943-017-0598-7
10.1038/nature11993
10.1261/rna.035667.112
10.1038/sj.onc.1210906
10.2741/4354
10.1038/nrg2521
10.1371/journal.pone.0016195
10.2174/156800908783769346
10.1007/s12032-010-9480-9
10.1242/bio.021774
10.18632/oncotarget.22846
10.1111/febs.14030
10.1093/abbs/gmx039
10.1097/PPO.0000000000000288
10.1002/jcb.10562
10.1038/cr.2015.82
10.1016/j.jbiotec.2016.09.011
10.3892/mmr.2015.3144
10.1097/01.cji.0000211339.81211.25
10.1371/journal.pone.0030733
10.1007/s12192-014-0532-5
10.1182/blood-2007-07-101311
10.1186/s12943-018-0827-8
10.1186/s13045-016-0370-2
10.1080/08820139.2017.1280051
10.4049/jimmunol.0800854
10.7150/jca.21749
10.1080/15476286.2016.1207036
10.18632/oncotarget.18129
10.1371/journal.pone.0114581
ContentType Journal Article
Copyright 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
2019 Informa UK Limited, trading as Taylor & Francis Group 2019 Informa UK Limited, trading as Taylor & Francis Group
Copyright_xml – notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
– notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019 Informa UK Limited, trading as Taylor & Francis Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1080/15476286.2019.1649585
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
AGRICOLA

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate Z.-L. OU ET AL
EISSN 1555-8584
EndPage 1603
ExternalDocumentID PMC6779391
31402756
10_1080_15476286_2019_1649585
1649585
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: HunanScience and Technology Plan Project
  grantid: 2017JJ3508
– fundername: ;
  grantid: 2017JJ3508
GroupedDBID ---
0YH
123
30N
4.4
53G
AAHBH
AAJMT
ABCCY
ABFIM
ABPEM
ABTAI
ACGFO
ACGFS
ACTIO
ADBBV
ADCVX
AEISY
AENEX
AEYOC
AHDZW
AIJEM
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
AQRUH
AVBZW
BAWUL
BLEHA
C1A
CCCUG
DGEBU
DIK
DKSSO
E3Z
EBS
EJD
EMOBN
F5P
FRP
GTTXZ
GX1
H13
HYE
IPNFZ
KYCEM
LJTGL
M4Z
O9-
OK1
P2P
RIG
RPM
SNACF
TDBHL
TEI
TFL
TFT
TFW
TR2
TTHFI
AAYXX
AIYEW
CITATION
0VX
ACZPZ
ADOPC
AURDB
BFWEY
BOHLJ
CGR
CUY
CVF
CWRZV
ECM
EIF
GROUPED_DOAJ
NPM
OVD
PCLFJ
TEORI
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c567t-ee3cc166d81dfb3e93fba47e5991cf3744e0c14bba86d9c9a9d81cc9709bb4ff3
ISSN 1547-6286
1555-8584
IngestDate Thu Aug 21 14:30:15 EDT 2025
Mon May 05 20:42:00 EDT 2025
Fri Jul 11 01:19:26 EDT 2025
Thu Apr 03 06:58:32 EDT 2025
Thu Apr 24 23:01:13 EDT 2025
Tue Jul 01 03:09:33 EDT 2025
Wed Dec 25 09:07:51 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords hypoxia
Pancreatic cancer (PC)
immune escape
circ_0000977
miR-153
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c567t-ee3cc166d81dfb3e93fba47e5991cf3744e0c14bba86d9c9a9d81cc9709bb4ff3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2444-5138
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.1080/15476286.2019.1649585?needAccess=true
PMID 31402756
PQID 2272216127
PQPubID 23479
PageCount 12
ParticipantIDs informaworld_taylorfrancis_310_1080_15476286_2019_1649585
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6779391
crossref_citationtrail_10_1080_15476286_2019_1649585
proquest_miscellaneous_2272216127
pubmed_primary_31402756
proquest_miscellaneous_2440693716
crossref_primary_10_1080_15476286_2019_1649585
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-02
PublicationDateYYYYMMDD 2019-11-02
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-02
  day: 02
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle RNA biology
PublicationTitleAlternate RNA Biol
PublicationYear 2019
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0030
CIT0010
CIT0032
CIT0031
CIT0012
CIT0034
Blay J (CIT0004) 1997; 57
CIT0011
Cortes-Lopez M (CIT0033) 2016; 89
CIT0014
CIT0013
CIT0035
CIT0016
CIT0038
CIT0015
CIT0018
CIT0017
Zhang Z (CIT0036) 2015; 8
CIT0039
CIT0019
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
Yuen A (CIT0002) 2014; 2
Wu X (CIT0037) 2016; 6
CIT0003
CIT0024
CIT0005
CIT0027
Guo S (CIT0025) 2018; 17
CIT0026
CIT0007
CIT0029
CIT0006
CIT0028
CIT0009
CIT0008
References_xml – volume: 57
  start-page: 2602
  issue: 13
  year: 1997
  ident: CIT0004
  publication-title: Cancer Res
– ident: CIT0008
  doi: 10.1158/0008-5472.CAN-11-2104
– ident: CIT0012
  doi: 10.3389/fphar.2018.00415
– ident: CIT0013
  doi: 10.3390/genes8120348
– ident: CIT0017
  doi: 10.1186/s12943-017-0598-7
– ident: CIT0026
  doi: 10.1038/nature11993
– ident: CIT0021
  doi: 10.1261/rna.035667.112
– ident: CIT0034
  doi: 10.1038/sj.onc.1210906
– ident: CIT0014
  doi: 10.2741/4354
– ident: CIT0011
  doi: 10.1038/nrg2521
– volume: 6
  start-page: 1563
  issue: 7
  year: 2016
  ident: CIT0037
  publication-title: Am J Cancer Res
– ident: CIT0006
  doi: 10.1371/journal.pone.0016195
– ident: CIT0031
  doi: 10.2174/156800908783769346
– ident: CIT0010
  doi: 10.1007/s12032-010-9480-9
– volume: 89
  start-page: 527
  issue: 4
  year: 2016
  ident: CIT0033
  publication-title: Yale J Biol Med
– ident: CIT0003
  doi: 10.1242/bio.021774
– ident: CIT0018
  doi: 10.18632/oncotarget.22846
– ident: CIT0024
  doi: 10.1111/febs.14030
– ident: CIT0038
  doi: 10.1093/abbs/gmx039
– ident: CIT0001
  doi: 10.1097/PPO.0000000000000288
– ident: CIT0005
  doi: 10.1002/jcb.10562
– ident: CIT0022
  doi: 10.1038/cr.2015.82
– ident: CIT0032
  doi: 10.1016/j.jbiotec.2016.09.011
– ident: CIT0009
  doi: 10.3892/mmr.2015.3144
– ident: CIT0028
  doi: 10.1097/01.cji.0000211339.81211.25
– volume: 8
  start-page: 357
  year: 2015
  ident: CIT0036
  publication-title: Onco Targets Ther
– ident: CIT0020
  doi: 10.1371/journal.pone.0030733
– ident: CIT0027
  doi: 10.1007/s12192-014-0532-5
– ident: CIT0039
  doi: 10.1182/blood-2007-07-101311
– volume: 2
  start-page: 91
  year: 2014
  ident: CIT0002
  publication-title: Hypoxia (Auckl)
– ident: CIT0019
  doi: 10.1186/s12943-018-0827-8
– ident: CIT0016
  doi: 10.1186/s13045-016-0370-2
– ident: CIT0029
  doi: 10.1080/08820139.2017.1280051
– volume: 17
  start-page: 7661
  issue: 6
  year: 2018
  ident: CIT0025
  publication-title: Mol Med Rep
– ident: CIT0007
  doi: 10.4049/jimmunol.0800854
– ident: CIT0023
  doi: 10.7150/jca.21749
– ident: CIT0035
  doi: 10.1080/15476286.2016.1207036
– ident: CIT0015
  doi: 10.18632/oncotarget.18129
– ident: CIT0030
  doi: 10.1371/journal.pone.0114581
SSID ssj0036895
Score 2.5635252
Snippet One key to malignant progression of pancreatic cancer (PC) is the acquired ability of tumour cells to escape immune-mediated lysis. Hypoxic microenvironment...
SourceID pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1592
SubjectTerms ADAM10 Protein - genetics
ADAM10 Protein - metabolism
Amyloid Precursor Protein Secretases - genetics
Amyloid Precursor Protein Secretases - metabolism
Cell Line, Tumor
Cell Survival
circ_0000977
Cytokines - metabolism
eosin
Gene Expression Regulation, Neoplastic
HEK293 Cells
Histocompatibility Antigens Class I - metabolism
Humans
hypoxia
hypoxia-inducible factor 1
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
immune escape
immunohistochemistry
Killer Cells, Natural - immunology
Membrane Proteins - genetics
Membrane Proteins - metabolism
messenger RNA
metalloproteinases
metastasis
microRNA
MicroRNAs - genetics
miR-153
monitoring
natural killer cells
neoplasm cells
non-coding RNA
Pancreatic cancer (PC)
pancreatic neoplasms
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - immunology
patients
Research Paper
RNA, Circular - genetics
Tumor Escape
Tumor Hypoxia
Up-Regulation
Title Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
URI https://www.tandfonline.com/doi/abs/10.1080/15476286.2019.1649585
https://www.ncbi.nlm.nih.gov/pubmed/31402756
https://www.proquest.com/docview/2272216127
https://www.proquest.com/docview/2440693716
https://pubmed.ncbi.nlm.nih.gov/PMC6779391
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTkJ7QcC4lJuMhHip0jWJEye8VYOpMKjQ1ImJlyhxnDUSTao2kTb-A7-KP8Y5dm4dFYO9JI1rJ2nPZ_sc-zvnEPJauqbwnMgyYuF6BotC6HMyZgZgwzGlF9quUNE-Z-70jH08d857vV8d1lJZRCPxY6dfyW2kCmUgV_SS_Q_JNjeFAvgM8oUjSBiO_yTj6dUqv0xDA-zqEvfxNwsZxxWNGQMdqJ2B6Ydjc2IoDxHULlN0CJFDuUHmk-I7g9yV5iiQASbkeoiL-RvteDI70Ve4cFATEUW6FoHS-tRG7DI9NWBAG4aX6aar6p7OJsMqxFOzkluqvZCFzC6MT2lLBirzurzdKFIsAzg1ldJ6ZXtRhml3scL0lddea9rO_8gb0h16GTfQUVbPTFWZ4xieo5PINeO128Wl2Rl9QTWzOjM5ZtDeOUtoWiU-EJ-H_D5_BGaj7-jsQR3krJYKOjaYoRgnv500Gyrjl89HLodBDiMo7Flgq1h9sjeZvvv2tVYIbNdTyX-aH1g7knnjw53vsE_u1A_c0pa2YunusoiuE3s7mtL8HrlbmTh0ovF6n_Rk9oAcTLKwyJdX9A1VpGOFiwPy8xqEaQ1hmicUIUwBwnQbwlRDmGoIY8UWwlRDmCrQUoQwnZ3oq7cUAYzVuwA-rOBLEb4Pydnx-_nR1KgyhBjCcXlhSGkLYbpuDFZXEtnSt5MoZFw6YPWIxOaMybEwWRSFnhv7wg99qCmEz8d-FLEksR-RfpZn8gmhzGQsjpPYAXuI8XESwo2FJUTiczOMEj4grJZEIKrw-ZjF5XtgVlF2a1kGKMugkuWAjJpmKx0_5qYGflfMQaG6TKJ7S2Df0PZVjYkAZgn8c8NM5uUmsCwAJhh3Fv9LHYZe8DY33QF5rHHUvHKNxwHhWwhrKmCU-u1vsnShotVXvePprVs-I_vtUPKc9It1KV-AJVBEL6ue9hv3BgA8
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDBa27rBd9uoe2VMDht2cxpYsWbsFw4J07XIYWqA3w6Il1OjqFIkDtPsP-88jZTtIim099GiYNCyZoj7K5EfGPjoVQ5baJCpBZZG0Ba45V8oIbSONXVYIBYHtc6amx_LbSXqyUQtDaZUUQ_uWKCL4alrcdBjdp8Tt4bavqaSSMrPMEAG_QdB7l91LjdLUxUCMZr03FioLnVdIJSKdvornX4_Z2p-22Ev_hkGvp1Ju7E2TRwz6UbUpKWfDVWOH8Osa4ePthv2YPeygKx-3tvaE3XH1U7Y7rjFsP7_in3hIJg2n9Lvs9_TqYn5ZFRGG_Gg8JV-eupK2ST73nDgYOL4Gn-5P4nEUilcQ-PKKalUcd0tKyiJB9FQtqAUOZJ0LTv8ZlpxqYvjsoL36zClDksShWkAe4KjWe-fVjwj9LC8uq-Uzdjz5evRlGnWdHyJIlW4i5wRArFSJaNpb4YzwtpDapYhmwQstpRtBLK0tMlUaMIVBSQCjR8Za6b14znbqee1eMi4xYixLX6aIc6Ue-QIfDAmANzourNcDJvvvnUNHi07dOX7mccee2k97TtOed9M-YMO12kXLC3KTgtk0prwJBzK-7Z6Sixt0P_SWl-Pqp8ktajdfLfMk0UmCoD3R_5GRVN0sMDAesBetta5fWWB8TQ0ABkxv2fFagNjHt-_U1WlgIVcaXbuJX91iXO_Z_enR98P8cH928Jo9oFuhzDN5w3aaxcq9RbzX2HdhQf8BqX5HZA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZgSIgXfg1G-WkkxJu7JnbsmLcKqDqGKoSYxJsVO7YWwdKqaaVt_8P-Z-6cpFonYA97rHIXxe75_F3y3WdC3nmZuDyzKSudzJmwBaw5XwoGsZElPi-4dFHtcyanR-LLz6xnEzYdrRJr6NAKRcRcjYt7UYaeEbcPu77CjkokZukh4H0NmPc2uSNRPBy7OEazPhlzmceDV9CFoU_fxPOv22xtT1vipX-DoFeZlJe2pskDYvtBtYyUX8P1yg7d-RW9xxuN-iG53wFXOm4j7RG55evHZHdcQ9F-ckbf00glje_od8nF9GwxP60KBgU_hE5Jm2Nf4iZJ54GiAgOFp6DTg0kyZrF1BWAvrbBTxVPfICULDSFPtZDWUYexuaT4laGh2BFDZ4ftrw8U-ZFo7qqlMxGMKrV_Un1nkGVpcVo1T8jR5POPj1PWnfvAXCbVinnPnUukLAFLB8u95sEWQvkMsKwLXAnhRy4R1ha5LLXThQZL57QaaWtFCPwp2anntX9GqIB6sSxDmQHKFWoUCrixS50LWiWFDWpARP93G9eJouPZHL9N0mmn9tNucNpNN-0DMty4LVpVkOsc9OVYMqv4Oia0Z6cYfo3v2z7wDKx9nNyi9vN1Y9JUpSlA9lT9x0ZgbzOHsnhA9tpg3Twyh-oa5f8HRG2F8cYAtce3r9TVcdQglwoSu06e32Bcb8jdb58m5uvB7PAFuYdXYo9n-pLsrJZr_wrA3sq-jsv5D2DRRgg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-induced+shedding+of+MICA+and+HIF1A-mediated+immune+escape+of+pancreatic+cancer+cells+from+NK+cells%3A+role+of+circ_0000977%2FmiR-153+axis&rft.jtitle=RNA+biology&rft.au=Ou%2C+Zheng-Lin&rft.au=Luo%2C+Zhen&rft.au=Wei%2C+Wei&rft.au=Liang%2C+Shuai&rft.date=2019-11-02&rft.pub=Taylor+%26+Francis&rft.issn=1547-6286&rft.eissn=1555-8584&rft.volume=16&rft.issue=11&rft.spage=1592&rft.epage=1603&rft_id=info:doi/10.1080%2F15476286.2019.1649585&rft_id=info%3Apmid%2F31402756&rft.externalDocID=PMC6779391
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1547-6286&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1547-6286&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1547-6286&client=summon